Red light therapy and ALS: hype, hope or both
A Curalysis blog examines photobiomodulation, also called red or near-infrared light therapy, as a possible approach in ALS. It describes proposed effects on cellular energy, inflammation and stem-cell activity, while acknowledging that most human studies are small and have short follow-up.
Why this matters
This may be relevant to people exploring experimental or complementary approaches, but the blog does not show that red light therapy improves ALS outcomes. The evidence discussed is mostly mechanistic, from other diseases or from early studies, so it does not currently change ALS treatment.
Limitations and context
This is a first-party blog and personal account, not a primary ALS clinical trial or independent evidence review. The article reports that human studies are generally small, methodologically uneven and short, and it provides no demonstrated clinical benefit for ALS. Larger, well-controlled ALS studies would be needed to establish effectiveness and safety in this population.